LebenGrida Co., Ltd., a company specializing in AI-based cognitive healthcare solutions, will introduce its latest artificial intelligence technologies for aging societies and cognitive health at CES 2026, taking place January 6–9 in Las Vegas.
According to the company, as global aging accelerates, dementia and cognitive decline are no longer individual concerns but critical challenges that society as a whole must address. At CES 2026, the application of artificial intelligence to aging societies and cognitive health is emerging as a key industry trend.
A New Approach Beyond Conventional Testing
LebenGrida goes beyond traditional one-time, test-based cognitive assessments by developing AI technology that analyzes older adults’ natural speech and reminiscence-based conversations as data. This approach removes the psychological burden associated with formal testing and enables continuous, repeated monitoring of cognitive changes over time.
Based on the company’s data, the AI system analyzes conversational and speech patterns to detect changes in cognitive function and delivers weekly, personalized cognitive training tailored to each individual. This method allows dementia risk to be compared over time and tracked continuously.
LebenGrida’s Solutions
At CES 2026, LebenGrida will present the following core solutions:
BrainUp
BrainUp is an AI-based cognitive observation and training solution that analyzes older adults’ natural speech and reminiscence conversations. It assesses cognitive status and provides personalized training content based on detected changes. BrainUp is designed primarily for institutional environments such as senior daycare centers and welfare facilities.
IWAS
IWAS is an interactive, web-based reminiscence and autobiographical storytelling service. Through a question-and-answer process, users share memories that are automatically transformed into personalized stories. These stories are paired with relevant images and simultaneously serve as valuable data sources for cognitive analysis.
According to LebenGrida, these solutions have demonstrated cognitive improvement effects in more than 5,000 users to date.
Patents and Scientific Foundation
LebenGrida holds multiple patents related to generative AI and AI-based cognitive diagnostic technologies. By focusing on speech and reminiscence data, the company is building a specialized AI platform that enables long-term tracking and comparison of cognitive changes.
LebenGrida at CES 2026
LebenGrida will welcome visitors at LVCC South Hall 2, Booth #36016 during CES 2026. The company invites media representatives, professionals, and partners to experience its next-generation cognitive healthcare solutions firsthand.
Through CES 2026, LebenGrida aims to showcase the future of cognitive health powered by artificial intelligence, continuous monitoring, and human-centered technology.